Citations (36)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Anders Løkke, Peter Lange, Jesper Lykkegaard, Rikke Ibsen, Maria Andersson, Sofie de Fine Licht & Ole Hilberg. (2021) Economic Burden of COPD by Disease Severity – A Nationwide Cohort Study in Denmark. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 603-613.
Read now
Read now
Arja Viinanen, Mariann I Lassenius, Iiro Toppila, Antti Karlsson, Lauri Veijalainen, Juhana J Idänpään-Heikkilä & Tarja Laitinen. (2019) The Burden Of Chronic Obstructive Pulmonary Disease (COPD) In Finland: Impact Of Disease Severity And Eosinophil Count On Healthcare Resource Utilization. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2409-2421.
Read now
Read now
Victoria S Benson, Katie C Pascoe, James Siddall, Mark Small & Hana Müllerová. (2019) Exacerbation Frequency And Eosinophil Counts Among Patients With COPD Currently Prescribed Triple Therapy. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2711-2723.
Read now
Read now
Arschang Valipour, Michael Tamm, Jana Kociánová, Valentina Bayer, Maria Sanzharovskaya, Alexey Medvedchikov, Monika Haaksma-Herczegh, János Mucsi, Zvi Fridlender, Claudia Toma, Andrey Belevskiy, Bohumil Matula & Jurij Šorli. (2019) Improvement In Self-Reported Physical Functioning With Tiotropium/Olodaterol In Central And Eastern European COPD Patients. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 2343-2354.
Read now
Read now
Helena Johansson, Carina Berterö, Katarina Berg & Lise-Lotte Jonasson. (2019) To live a life with COPD – the consequences of symptom burden. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 905-909.
Read now
Read now
Anna Muñoz, Mark Small, Robert Wood, Anna Ribera & Javier Nuevo. (2018) The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1557-1568.
Read now
Read now
Margarethe E Wacker, Katharina Kitzing, Rudolf A Jörres, Reiner Leidl, Holger Schulz, Stefan Karrasch, Annika Karch, Armin Koch, Claus F Vogelmeier & Rolf Holle. (2017) The contribution of symptoms and comorbidities to the economic impact of COPD: an analysis of the German COSYCONET cohort. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3437-3448.
Read now
Read now
Articles from other publishers (29)
Susan A Carlson, Anne G Wheaton, Yong Liu, Latetia V Moore, Paul I Eke, Janet B Croft, Kurt J Greenlund & Craig W Thomas. (2021) Associations of self-reported chronic obstructive pulmonary disease with indicators of economic instability and stress – 16 states, 2017. Chronic Illness 19:2, pages 327-338.
Crossref
Crossref
Niamh Kelly, Kyra Gormley, Dermot A. Linden, Lewis Winning, Mary McClory, Fionnuala T. Lundy, Kathy M. Cullen, Gerard J. Linden & Ikhlas A. El Karim. (2023) The association of denture wearing with reduced lung function and increased airflow limitation in 58–72 year old men. PLOS ONE 18:5, pages e0285117.
Crossref
Crossref
Qing Song, Ling Lin, Wei Cheng, Xue-Shan Li, Yu-Qin Zeng, Cong Liu, Min-Hua Deng, Dan Liu, Zhi-Ping Yu, Xin Li, Li-Bing Ma, Yan Chen, Shan Cai & Ping Chen. (2023) Clinical–functional characteristics and risk of exacerbation and mortality among more symptomatic patients with chronic obstructive pulmonary disease: a retrospective cohort study. BMJ Open 13:3, pages e065625.
Crossref
Crossref
Vivek C. Pandrangi, Jess C. Mace, Jee‐Hong Kim, Mathew Geltzeiler, Kara Y. Detwiller, Zachary M. Soler, Rodney J. Schlosser, Jeremiah A. Alt, Vijay R. Ramakrishnan, Jose L. Mattos & Timothy L. Smith. (2022) Work productivity and activity impairment in patients with chronic rhinosinusitis undergoing endoscopic sinus surgery—A prospective, multi‐institutional study. International Forum of Allergy & Rhinology 13:3, pages 216-229.
Crossref
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Yahong Chen, Wenhua Jian, Hongyan Shang & Chen Wang. (2022) Severity distribution and treatment of chronic obstructive pulmonary disease in China: baseline results of an observational study. Respiratory Research 23:1.
Crossref
Crossref
Subhasis Mukherjee, R. Chakraborti & D.K. Mukhopadhyay. (2022) Physical, Psycho-social and Economic Burden of Chronic Obstructive Pulmonary Disease: A Hospital-Based Study in Kolkata, West Bengal, India. The Indian Journal of Chest Diseases and Allied Sciences 63:2, pages 81-88.
Crossref
Crossref
Nigel S. Cook, Gerard J. Criner, Pierre-Régis Burgel, Katie Mycock, Tom Gardner, Phil Mellor, Pam Hallworth, Kate Sully, Sophi Tatlock, Beyza Klein, Byron Jones, Olivier Le Rouzic, Kip Adams, Kirsten Phillips, Mike McKevitt, Kazuko Toyama & Florian S. Gutzwiller. (2022) People living with moderate-to-severe COPD prefer improvement of daily symptoms over the improvement of exacerbations: a multicountry patient preference study. ERJ Open Research 8:2, pages 00686-2021.
Crossref
Crossref
Hans-Peter KapfhammerHans-Peter Kapfhammer. 2022. Depression, Angst, traumatischer Stress und internistische Erkrankungen. Depression, Angst, traumatischer Stress und internistische Erkrankungen
289
378
.
Omar Melhem, Eileen Savage, Nathira Al Hmaimat, Elaine Lehane & Hadya Abdel Fattah. (2021) Symptom burden and functional performance in patients with chronic obstructive pulmonary disease. Applied Nursing Research 62, pages 151510.
Crossref
Crossref
Andreas Halner, Sally Beer, Richard Pullinger, Mona Bafadhel & Richard E. K. Russell. (2021) Predicting treatment outcomes following an exacerbation of airways disease. PLOS ONE 16:8, pages e0254425.
Crossref
Crossref
Ahmed Salem, Heng Zhong, Mafalda Ramos, Mark Lamotte & Hao Hu. (2021) Potential clinical and economic impact of optimised maintenance therapy on discharged patients with COPD after hospitalisation for an exacerbation in China. BMJ Open 11:4, pages e043664.
Crossref
Crossref
Boudewijn J. H. Dierick, Bertine M. J. Flokstra-de Blok, Thys van der Molen, Núria Toledo-Pons, Miguel Román-Rodríguez, Borja G. Cosío, Joan B. Soriano, Janwillem W. H. Kocks & Job F. M. van Boven. (2021) Work absence in patients with asthma and/or COPD: a population-based study. npj Primary Care Respiratory Medicine 31:1.
Crossref
Crossref
Omar Melhem, Eileen Savage & Elaine Lehane. (2021) Symptom burden in patients with chronic obstructive pulmonary disease. Applied Nursing Research 57, pages 151389.
Crossref
Crossref
Gamze MUZ, Ayser ERAT, Şeydanur ŞAMDANLI & Nisa YAVUZER. (2020) Use of integrative medicines by chronic obstructive pulmonary disease patients and its relation with hopelessness levelsKronik obstrüktif akciğer hastalığı tanısı almış bireylerin integratif yöntemleri kullanma durumu ve umutsuzluk düzeyleri ile ilişkisi. Cukurova Medical Journal 45:4, pages 1598-1606.
Crossref
Crossref
Ting Yang, Baiqiang Cai, Bin Cao, Jian Kang, Fuqiang Wen, Wanzhen Yao, Jinping Zheng, Xia Ling, Hongyan Shang & Chen Wang. (2020) REALizing and improving management of stable COPD in China: a multi-center, prospective, observational study to realize the current situation of COPD patients in China (REAL) – rationale, study design, and protocol. BMC Pulmonary Medicine 20:1.
Crossref
Crossref
Sarah Oslislo, Christoph Heintze, Martin Möckel, Liane Schenk & Felix Holzinger. (2020) What role does the GP play for emergency department utilizers? A qualitative exploration of respiratory patients’ perspectives in Berlin, Germany. BMC Family Practice 21:1.
Crossref
Crossref
Tamas ErdelyiZsofia LazarBalazs OdlerLilla TamasiVeronika Müller. (2020) The Repeatability of Inspiration Performance Through Different Inhalers in Patients with Chronic Obstructive Pulmonary Disease and Control Volunteers. Journal of Aerosol Medicine and Pulmonary Drug Delivery 33:5, pages 271-281.
Crossref
Crossref
Maggie Tabberer, C. Elaine Jones, Sally Kilbride, David M. G. Halpin, David A. Lomas, Steven Pascoe, Dave Singh, Robert A. Wise, Gerard J. Criner, Peter Lange, Mark T. Dransfield, MeiLan K. Han, Fernando J. Martinez, Morrys C. Kaisermann & David A. Lipson. (2020) Single-Inhaler Triple Therapy and Health-Related Quality of Life in COPD: The IMPACT Study. Advances in Therapy 37:9, pages 3775-3790.
Crossref
Crossref
Brittany Koons, John R. Greenland, Joshua M. Diamond & Jonathan P. Singer. (2020) Pathobiology of frailty in lung disease. Translational Research 221, pages 1-22.
Crossref
Crossref
Carla Malaguti, Simone Dal Corso, Sadia Janjua & Anne E Holland. (2020) Supervised maintenance programs following pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Chen Wang, Ting Yang, Jian Kang, Rongchang Chen, Li Zhao, Huijie He, Pryseley N. Assam, Rong Su, Eric Bourne, Shaila Ballal, Kiernan DeAngelis & Paul Dorinsky. (2020) Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler in Chinese Patients with COPD: A Subgroup Analysis of KRONOS. Advances in Therapy 37:4, pages 1591-1607.
Crossref
Crossref
Anees ur Rehman, Mohamed Azmi Ahmad Hassali, Sohail Ayaz Muhammad, Sabariah Noor Harun, Shahid Shah & Sameen Abbas. (2019) The economic burden of chronic obstructive pulmonary disease (COPD) in Europe: results from a systematic review of the literature. The European Journal of Health Economics 21:2, pages 181-194.
Crossref
Crossref
Zijing Zhou, Aiyuan Zhou, Yating Peng, Jiaxi Duan, Yuqin Zeng, Yiyang Zhao, Wei Cheng & Ping Chen. (2020) Determinants of Clinical COPD Questionnaire in Patients with COPD: A Cross-Sectional Observational Study. Respiration 99:7, pages 606-616.
Crossref
Crossref
Catherine Le Berre, Laurent Peyrin-Biroulet, Anne Buisson, Alain Olympie, Marie-Hélène Ravel, Christina Bienenfeld & Florent Gonzalez. (2019) Impact of inflammatory bowel diseases on working life: A French nationwide survey. Digestive and Liver Disease 51:7, pages 961-966.
Crossref
Crossref
Ting-Chia Weng, Han-Yi Robert Chiu, Shey-Ying Chen, Fuh-Yuan Shih, Chwan-Chuen King & Cheng-Chung Fang. (2019) National retrospective cohort study to identify age-specific fatality risks of comorbidities among hospitalised patients with influenza-like illness in Taiwan. BMJ Open 9:6, pages e025276.
Crossref
Crossref
Beth Hahn, Richard H. Stanford, Alyssa Goolsby Hunter, Breanna Essoi, John White & Riju Ray. (2019) Patient-Reported Burden of Illness in a Prevalent COPD Population Treated with Long-Acting Muscarinic Antagonist Monotherapy: A Claims-Linked Patient Survey Study. Pulmonary Therapy 5:1, pages 69-80.
Crossref
Crossref
Nigel S. Cook, Konstantinos Kostikas, Jean-Bernard Gruenberger, Bhavik Shah, Purnima Pathak, Vinay Preet Kaur, Alaknanda Mudumby, Rajat Sharma & Florian S. Gutzwiller. (2019) Patients' perspectives on COPD: findings from a social media listening study. ERJ Open Research 5:1, pages 00128-2018.
Crossref
Crossref
K K Rai, P Adab, J G Ayres & R E Jordan. (2018) Systematic review: chronic obstructive pulmonary disease and work-related outcomes. Occupational Medicine 68:2, pages 99-108.
Crossref
Crossref
Gao Zhen, Jing Jing, Xu Dan, Li Zheng, Li Fengsen & Sun Qi. (2017) A Randomized Controlled Study of the Yi Qi Gu Biao Pill in the Treatment of Frequent Exacerbator Phenotype in Chronic Obstructive Pulmonary Disease (Lung and Spleen Qi Deficiency Syndrome). Evidence-Based Complementary and Alternative Medicine 2017, pages 1-10.
Crossref
Crossref